- Home
- BOF vs CLRB Comparison
BOF vs CLRB Comparison
Compare BOF & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOF
- CLRB
- Stock Information
- Founded
- BOF 2017
- CLRB 2002
- Country
- BOF United States
- CLRB United States
- Employees
- BOF N/A
- CLRB N/A
- Industry
- BOF Packaged Foods
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- BOF Consumer Staples
- CLRB Health Care
- Exchange
- BOF Nasdaq
- CLRB Nasdaq
- Market Cap
- BOF 15.1M
- CLRB 15.3M
- IPO Year
- BOF 2023
- CLRB N/A
- Fundamental
- Price
- BOF $1.91
- CLRB $0.31
- Analyst Decision
- BOF
- CLRB Buy
- Analyst Count
- BOF 0
- CLRB 2
- Target Price
- BOF N/A
- CLRB $28.00
- AVG Volume (30 Days)
- BOF 140.5K
- CLRB 1.4M
- Earning Date
- BOF 04-01-2025
- CLRB 03-26-2025
- Dividend Yield
- BOF N/A
- CLRB N/A
- EPS Growth
- BOF N/A
- CLRB N/A
- EPS
- BOF N/A
- CLRB N/A
- Revenue
- BOF $6,489,951.00
- CLRB N/A
- Revenue This Year
- BOF N/A
- CLRB N/A
- Revenue Next Year
- BOF N/A
- CLRB N/A
- P/E Ratio
- BOF N/A
- CLRB N/A
- Revenue Growth
- BOF 372.36
- CLRB N/A
- 52 Week Low
- BOF $0.61
- CLRB $0.22
- 52 Week High
- BOF $4.11
- CLRB $4.45
- Technical
- Relative Strength Index (RSI)
- BOF 39.91
- CLRB 46.10
- Support Level
- BOF $2.40
- CLRB $0.26
- Resistance Level
- BOF $2.59
- CLRB $0.35
- Average True Range (ATR)
- BOF 0.20
- CLRB 0.03
- MACD
- BOF -0.08
- CLRB 0.02
- Stochastic Oscillator
- BOF 7.50
- CLRB 61.40
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.